methamphetamine and 1-methyl-4-phenylpyridinium

methamphetamine has been researched along with 1-methyl-4-phenylpyridinium in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19902 (12.50)18.7374
1990's8 (50.00)18.2507
2000's3 (18.75)29.6817
2010's2 (12.50)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Ganapathy, V; Leibach, FH; Prasad, PD; Wu, X1
Chen, J; Conway, SJ; Fei, YJ; Ganapathy, V; Huang, W; Kekuda, R; Leibach, FH; Wu, X1
Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X1
Dunnett, SB; Morris, BJ; Northrop, AJ; Sirinathsinghji, DJ1
Beresford, IJ; Hall, MD; Heavens, RP; Richards, SJ; Sirinathsinghji, DJ1
Carelli, RM; Jarvis, MF; Wagner, GC1
Edwards, RH; Jimenez, J; Kim, J; Liu, Y; Peter, D1
Budai, G; Kardos, V; Pátfalusi, M; Patthy, M; Sziráki, I1
Albers, DS; Moy, LY; Sonsalla, PK1
Eshleman, AJ; Janowsky, A; Johnson, RA; Meyers, T; Neve, KA1
Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB1
Obata, T; Yamanaka, Y1
Kim, S; McCann, UD; Ricaurte, GA; Xie, T; Yuan, J1
Ayestas, MA; Baumann, MH; Brandt, SD; Cozzi, NV; Daley, PF; Partilla, JS; Rothman, RB; Ruoho, AE; Shulgin, AT; Sink, JR1
Cosconati, S; Da Settimo, F; Daniele, S; Fornai, F; Martini, C; Pugliesi, I; Scatena, A; Taliani, S; Trincavelli, ML1
Biagioni, F; Busceti, CL; Ferrucci, M; Fornai, F; Frati, A; Lazzeri, G; Lenzi, P; Puglisi-Allegra, S1

Other Studies

16 other study(ies) available for methamphetamine and 1-methyl-4-phenylpyridinium

ArticleYear
cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.
    Biochemical and biophysical research communications, 1998, May-29, Volume: 246, Issue:3

    Topics: Amines; Amino Acid Sequence; Base Sequence; Biological Transport; Carrier Proteins; Chromosomes, Human, Pair 5; Cloning, Molecular; DNA, Complementary; Guanidines; Human Genome Project; Humans; Ions; Membrane Proteins; Membrane Transport Proteins; Molecular Sequence Data; Organic Cation Transport Proteins; Pyridines; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Solute Carrier Family 22 Member 5; Symporters; Tetraethylammonium

1998
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain.
    The Journal of biological chemistry, 1998, Dec-04, Volume: 273, Issue:49

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Biogenic Monoamines; Brain; Carrier Proteins; Cell Line; HeLa Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Neurotoxins; Neurotransmitter Agents; Oocytes; Rats; Xenopus laevis

1998
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3

    Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium

1999
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Neuroscience, 1990, Volume: 37, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Autoradiography; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Female; Fetal Tissue Transplantation; Immunohistochemistry; Injections; Methamphetamine; Neural Pathways; Parkinson Disease, Secondary; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra

1990
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Neuroscience, 1988, Volume: 27, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Female; Functional Laterality; Methamphetamine; Parkinson Disease, Secondary; Posture; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra

1988
Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.
    Neuropharmacology, 1986, Volume: 25, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Ascorbic Acid; Dopamine; Herbicides; Male; Methamphetamine; Pyridinium Compounds; Rats

1986
The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.
    The Journal of biological chemistry, 1994, Mar-11, Volume: 269, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Biogenic Monoamines; Biological Transport; Carrier Proteins; CHO Cells; Chromaffin Granules; Cricetinae; DNA, Complementary; Methamphetamine; Synapses; Vesicular Monoamine Transport Proteins

1994
Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
    European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons

1994
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Brain research, 1998, Apr-20, Volume: 790, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Methamphetamine; Mice; MPTP Poisoning; Nerve Degeneration; Neurons; Neurotoxins; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase

1998
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Synapse (New York, N.Y.), 1998, Volume: 30, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Calcium; Carrier Proteins; Cloning, Molecular; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glioma; Half-Life; Humans; Imipramine; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Rats; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transfection; Tritium

1998
Expression of the extraneuronal monoamine transporter in RPE and neural retina.
    Current eye research, 2000, Volume: 20, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors

2000
Methamphetamine enhances 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in the rat striatum.
    Neuroscience letters, 2000, Sep-29, Volume: 292, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Uptake Inhibitors; Drug Synergism; Electrochemistry; Hydroxyl Radical; Male; Methamphetamine; Microdialysis; Rats; Rats, Wistar; Stereotaxic Techniques

2000
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Oct-15, Volume: 20, Issue:20

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Brain; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intracellular Fluid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Neuroblastoma; Neurons; Rats; Rats, Sprague-Dawley; Temperature

2000
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electrochemistry; Hallucinogens; In Vitro Techniques; Locomotion; Male; Membrane Transport Proteins; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes; Time Factors; Tritium

2012
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.
    ACS chemical neuroscience, 2011, Sep-21, Volume: 2, Issue:9

    Topics: 1-Methyl-4-phenylpyridinium; Adenosine A2 Receptor Antagonists; Animals; Benzimidazoles; Cell Death; Cell Survival; CHO Cells; Computer Simulation; Cricetinae; Cyclic AMP; Humans; Indicators and Reagents; Membranes; Methamphetamine; Neuroprotective Agents; Neurotoxins; PC12 Cells; Rats; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Triazines

2011
Bacopa Protects against Neurotoxicity Induced by MPP
    Molecules (Basel, Switzerland), 2022, Aug-15, Volume: 27, Issue:16

    Topics: 1-Methyl-4-phenylpyridinium; Bacopa; Catecholamines; Methamphetamine; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Reactive Oxygen Species

2022